- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01900210
Sustainable HIV Risk Reduction Strategies for CJ Systems (DRR)
Sustainable Disease Risk Reduction Strategies for CJ Systems
Study Overview
Detailed Description
The purpose of the TCU DRR Project is to develop and test an intervention designed to increase positive decision-making skills among offenders for healthy living, including skills for making decisions for reducing disease risk behaviors. This project focuses on risky sexual and drug use behaviors during re-entry, including problem recognition, commitment to change, and strategies for avoiding behavioral risks of infections. Motivational and planning sessions will be delivered near the end of criminal justice (CJ) institution-based substance abuse treatment, and they will also bridge into re-entry care services during community transitional treatment by using a self-study toolkit for released offenders that emphasize applications of DRR principles. This 5-year project has been funded by the National Institute on Drug Abuse.
The intervention has two components - an in-prison and a post-release component.
• The in-prison component, WaySafe, is a six session, manual-based training on decision-making skills that occurs during the last several months of treatment before release from incarceration. It is a group-based, interactive curriculum based on TCU Mapping Enhanced Counseling strategies, which are used to visually enhance communication between clients and counselors. Homework assignments are given to be completed between the weekly sessions. The six hour-long WaySafe sessions are conducted by current counselors at the facility who have been trained in the curriculum.
For comparison purposes, some offenders who voluntarily agree to participate in the DRR study are randomly assigned to attend "treatment as usual." All participants in the study first sign an Informed Consent document indicating that their participation is voluntary and that they have been informed about their rights as research participants. They are also asked to complete a brief pre-test at the beginning of the study and a brief post-test at the end of the six-week period. A signed Certificate of Completion is given to all participants who complete the study.
• The post-release component, Keep It Safe, is a self-study toolkit given to offenders when they are released from incarceration, using mapping principles similar to those in the WaySafe sessions. It is designed to reinforce decision-making skills during this transition period and includes multiple assignments on topics such as risk taking, making better decisions regarding risky behaviors, and decisions regarding HIV testing.
For comparison purposes, some offenders are randomly selected to receive a booklet that includes readings on HIV and Hepatitis B&C derived from National Institutes of Health (NIH) and Center for Disease Control (CDC) materials, with short quizzes after each section. Both the Keep It Safe and CDC Readings booklets are designed to take about five hours to complete including a final follow-up survey in each booklet. Offenders are asked to mail their completed booklets directly to TCU in a provided pre-addressed, franked envelope. A Certificate of Completion is mailed directly to the participant when the completed workbook and follow-up survey is received at TCU project offices.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Incarcerated offenders in eight participating facilities in two states entering the last phase of their prison-based substance abuse treatment.
Exclusion Criteria:
- Sex offenders or those convicted of a violent crime.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: WaySafe
WaySafe -- Participants in this arm received a curriculum titled WaySafe that focused on identifying, planning for, and avoiding HIV risk behaviors after release from prison.
WaySafe included 6 hour-long, group-based, highly interactive sessions normally held weekly with homework assignments given between sessions.
|
|
|
No Intervention: Treatment as usual
Participants in this arm completed pre- and post-surveys and attended normal substance abuse programming.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
HIV Knowledge Confidence (change from pre-test to post-test)
Time Frame: One week prior to the intervention start (for both experiemental and control arms) and one week after the intervention
|
13 item scale comprised of items assessing knowledge, confidence and motivation regarding HIV knowledge (alpha = .89.
Responses on a 5-point "strongly disagree" to "strongly agree" scale.
Sample item -- "You should know enough to teach others what they should do if they have been exposed to HIV."
|
One week prior to the intervention start (for both experiemental and control arms) and one week after the intervention
|
|
Avoiding Risky Sex (change from pre-test to post-test)
Time Frame: One week prior to the intervention start (for both experiemental and control arms) and one week after the intervention
|
13 item scale comprised of items assessing knowledge, confidence and motivation regarding avoiding risky sex behaviors (alpha = .91.
Responses on a 5-point "strongly disagree" to "strongly agree" scale.
Sample item -- "You have learned to think ahead in order to make less risky decisions about sex."
|
One week prior to the intervention start (for both experiemental and control arms) and one week after the intervention
|
|
Avoiding Risky Drug Use (change from pre-test to post-test)
Time Frame: One week prior to the intervention start (for both experiemental and control arms) and one week after the intervention
|
12 item scale comprised of items assessing knowledge, confidence and motivation regarding avoiding risky drug use behaviors (alpha = .85.
Responses on a 5-point "strongly disagree" to "strongly agree" scale.
Sample item -- "If you decide to inject drugs, you will always use a 'clean needle'."
|
One week prior to the intervention start (for both experiemental and control arms) and one week after the intervention
|
|
HIV Testing Awareness (change from pre-test to post-test)
Time Frame: One week prior to the intervention start (for both experiemental and control arms) and one week after the intervention
|
7 item scale comprised of items assessing knowledge and motivation regarding getting tested for HIV (alpha = .76).
Responses on a 5-point "strongly disagree" to "strongly agree" scale.
Sample item -- "You plan on being tested regularly for HIV."
|
One week prior to the intervention start (for both experiemental and control arms) and one week after the intervention
|
|
Risk Reduction Skills (change from pre-test to post-test)
Time Frame: One week prior to the intervention start (for both experiemental and control arms) and one week after the intervention
|
14 item scale comprised of items assessing knowledge, confidence and motivation regarding identifying, planning for, and avoiding risk situations (alpha = .85).
Responses on a 5-point "strongly disagree" to "strongly agree" scale.
Sample item -- "You know how to stand up for yourself when pressured to take a risk."
|
One week prior to the intervention start (for both experiemental and control arms) and one week after the intervention
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Wayne E Lehman, Ph.D., Institute of Behavioral Research, Texas Christian University
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- DA25885-Sum08-13
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV Risk Behaviors
-
National Institute on Drug Abuse (NIDA)Wayne State UniversityUnknownHealth Behaviors | Adherence | HIV Risk Behaviors | Alcohol & Drug Use | Sexual Risk BehaviorsUnited States
-
Massachusetts General HospitalNational Institute of Mental Health (NIMH); Fenway Community Health; Tuberculosis...CompletedHIV/STI Risk | HIV/STI IncidenceUnited States, India
-
University of PennsylvaniaNational Institute on Drug Abuse (NIDA)CompletedHIV Risk Behaviors | Heroin Injection | Retention in Methadone TreatmentIndonesia
-
Groupe d'Etude sur le Risque d'Exposition des Soignants...Gilead SciencesCompleted
-
The University of AkronBrown University; The Miriam Hospital; Indiana UniversityCompleted
-
Rhode Island HospitalNational Institute on Drug Abuse (NIDA)Completed
-
University of RochesterNational Institute of Mental Health (NIMH)Completed
-
Yale UniversityCompleted
-
Duke UniversityIntelligent Automation, Inc.Completed
-
University of California, San DiegoNational Institute of Mental Health (NIMH); Indian Council of Medical Research and other collaboratorsCompletedBehavioral Risk for HIVIndia